𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF

✍ Scribed by Stephen J. Kim; Hassanain S. Toma; Joshua M. Barnett; John S. Penn

Book ID
116457104
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
987 KB
Volume
91
Category
Article
ISSN
0014-4835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

VEGF-TRAPR1R2 suppresses choroidal neova
VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood–retinal barrier
✍ Yoshitsugu Saishin; Yumiko Saishin; Kyoichi Takahashi; Raquel Lima e Silva; Donn πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 301 KB

Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema. There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization. In this study, we investigated the effect of a specific

Increased expression of VEGF in retinal
Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization
✍ Yuji Oshima; Sachiko Oshima; Hiroyuki Nambu; Shu Kachi; Sean F. Hackett; Michele πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 331 KB

## Abstract Increased expression of vascular endothelial cell growth factor (VEGF) in the retina is sufficient to stimulate sprouting of neovascularization from the deep capillary bed of the retina, but not the superficial retinal capillaries or the choriocapillaris. Coexpression of VEGF and angiop

Topical administration of a multi-target
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema
✍ John Doukas; Sankaranarayana Mahesh; Naoyasu Umeda; Shu Kachi; Hideo Akiyama; Ka πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 353 KB

## Abstract Age‐related macular degeneration, diabetic retinopathy, and retinal vein occlusions are complicated by neovascularization and macular edema. Multi‐targeted kinase inhibitors that inhibit select growth factor receptor tyrosine kinases and/or components of their down‐stream signaling casc